Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MEDP Medpace

Trading 03-10 12:51:04 EDT

470.61

-7.93

-1.66%

High479.00	Low463.32	Vol129.69K
Open477.00	D1 Closing478.54	Amplitude3.28%
Mkt Cap13.36B	Tradable Cap10.46B	Total Shares28.38M
T/O61.06M	T/O Rate0.58%	Tradable Shares22.22M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace","latestPrice":470.605,"timestamp":1773161442666,"preClose":478.54,"halted":0,"volume":129693,"delay":0,"changeRate":-0.01658168596146613,"floatShares":22220178,"shares":28381283,"eps":15.28,"marketStatus":"Trading","change":-7.935,"latestTime":"03-10 12:51:04 EDT","open":477,"high":479,"low":463.32,"amount":61062328.02144001,"amplitude":0.032766,"askPrice":472.05,"askSize":49,"bidPrice":469.47,"bidSize":6,"shortable":3,"etf":0,"ttmEps":15.28,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":478.54,"postHourTrading":{"tag":"盘后","latestPrice":478.54,"preClose":478.54,"latestTime":"19:58 EDT","volume":3570,"amount":1708333.7087,"timestamp":1773100733365,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.819506,"impliedVol":0.3917,"impliedVolPercentile":0.3944},"requestUrl":"/m/hq/s/MEDP","defaultTab":"news","newsList":[{"id":"2617635889","title":"Medpace Holdings Raised to Equal-Weight From Underweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2617635889","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617635889?lang=en_us&edition=fundamental","pubTime":"2026-03-06 22:15","pubTimestamp":1772806500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MEDP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2026 09:15 ET (14:15 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"gpt_icon":0},{"id":"2616324050","title":"Medpace is Differentiated as Most Efficient Contract Research Organization, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2616324050","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616324050?lang=en_us&edition=fundamental","pubTime":"2026-03-03 23:57","pubTimestamp":1772553422,"startTime":"0","endTime":"0","summary":"Medpace  is differentiated as the most efficient contract research organization per employee and is positioned to benefit from biopharma end markets expected to see robust clinical trial activity, RBC Capital Markets said in a Monday research report.The company's growing efficiency is a byproduct of investment in training and prudent hiring in recent years. Any increase in hiring could be a safe indicator of steady demand signals, according to the note.The recent uptick in trial cancellations looks transitory, not structural, and is more suspension-focused while terminations trended downward, according to RBC.The brokerage said it initiated coverage of the stock with an outperform rating and a price target of $522 per share.Price: 448.58, Change: -8.89, Percent Change: -1.94","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065170008.USD","LU2065169927.USD","LU2065171311.SGD","BK4588","LU2065171402.SGD","MEDP","BK4585","BK4121"],"gpt_icon":0},{"id":"2616932454","title":"Medpace Holdings Initiated at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2616932454","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616932454?lang=en_us&edition=fundamental","pubTime":"2026-03-03 23:33","pubTimestamp":1772551980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MEDP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2026 10:33 ET (15:33 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"gpt_icon":0},{"id":"2616341747","title":"RBC Initiates Medpace Holdings at Outperform With $522 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2616341747","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616341747?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:33","pubTimestamp":1772537599,"startTime":"0","endTime":"0","summary":"Medpace Holdings (MEDP) has an average rating of hold and mean price target of $503, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"gpt_icon":0},{"id":"2616393138","title":"Medpace initiated with an Outperform at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2616393138","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616393138?lang=en_us&edition=fundamental","pubTime":"2026-03-03 08:40","pubTimestamp":1772498410,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Ryan Halsted initiated coverage of Medpace (MEDP) with an Outperform rating and $522 price target The company is the most effic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-initiated-with-an-outperform-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-initiated-with-an-outperform-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"2612944913","title":"Levi & Korsinsky Probes Medpace Holdings Over Securities Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2612944913","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612944913?lang=en_us&edition=fundamental","pubTime":"2026-02-18 22:02","pubTimestamp":1771423350,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky has opened an investigation into Medpace Holdings over potential securities law claims, focusing on whether the company misrepresented the health of its clinical-trial bookings pipeline amid elevated cancellations and a weakening book-to-bill ratio. The probe follows Medpace’s disclosure of a Q4 2025 book-to-bill ratio of 1.04 and a subsequent share-price drop of about 15.9%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL81sXV4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065171311.SGD","BK4585","MEDP","LU2065169927.USD","BK4121","LU2065171402.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"2612448554","title":"Medpace Holdings Inc : TD Cowen Raises to Hold From Sell; Cuts Target Price to $419 From $462","url":"https://stock-news.laohu8.com/highlight/detail?id=2612448554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612448554?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:01","pubTimestamp":1771416091,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZE0HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU2065171311.SGD","LU2065169927.USD","BK4588","LU2065170008.USD","BK4585","LU2065171402.SGD","MEDP"],"gpt_icon":0},{"id":"2612307417","title":"Medpace upgraded to Hold from Sell at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2612307417","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612307417?lang=en_us&edition=fundamental","pubTime":"2026-02-18 18:55","pubTimestamp":1771412116,"startTime":"0","endTime":"0","summary":"TD Cowen upgraded Medpace (MEDP) to Hold from Sell with a price target of $419, down from $462. The shares have re-rated from a peak multiple and n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-upgraded-to-hold-from-sell-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-upgraded-to-hold-from-sell-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","MEDP","TD"],"gpt_icon":0},{"id":"2611412228","title":"Pinterest, DraftKings, And Flutter Are Among Top 10 Large Cap Losers Last Week (Feb. 9-Feb. 13): Are the Others in Your Portfolio?","url":"https://stock-news.laohu8.com/highlight/detail?id=2611412228","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611412228?lang=en_us&edition=fundamental","pubTime":"2026-02-15 21:32","pubTimestamp":1771162320,"startTime":"0","endTime":"0","summary":"Pinterest, DraftKings, and Astera Labs led last week's large-cap losers as cautious outlooks and post-earnings guidance/downgrades sparked a broad pullback across tech, housing, and gaming names.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/15/Spokane--Wa---usa---June-2020-View-Of-Dr.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/15/Spokane--Wa---usa---June-2020-View-Of-Dr.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/02/50634529/pinterest-draftkings-and-flutter-are-among-top-10-large-cap-losers-last-week-feb-9-feb-13-are-the-others-in-your-portfolio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/02/50634529/pinterest-draftkings-and-flutter-are-among-top-10-large-cap-losers-last-week-feb-9-feb-13-are-the-others-in-your-portfolio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0477156953.USD","BK4585","DKNG","IE0009354923.USD","BK4539","LU2089985449.USD","MEDP","SGXZ81514606.USD","LU2065169927.USD","LU0320765489.SGD","KRMN","BK4141","LU1496350502.SGD","LU2290526834.HKD","Z","LU1201861249.SGD","LU2360107168.USD","LU0130102774.USD","LU0274383776.USD","LU1496350171.SGD","BK4548","LU1861220033.SGD","LU0130517989.USD","BK4173","BK4089","LU0575583348.USD","LU0208291251.USD","BK4187","RYAN","PINS","LU2931357623.SGD","SGXZ51526630.SGD","BK4551","FLUT","LU0154245673.USD","LU2065171311.SGD","SG9999004253.SGD","LU1015430645.USD","BK4121","LU2065170008.USD","LU2065171402.SGD","BK4079","SG9999001077.SGD","SGXZ99366536.SGD","LU0070302665.USD","BK4150","CBRE","LU1861215975.USD","LU0980610538.SGD","BK4588","LABX","LU0154245756.USD","LU0648001328.SGD"],"gpt_icon":1},{"id":"2611198569","title":"Medpace Holdings Raised to Buy From Hold by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2611198569","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611198569?lang=en_us&edition=fundamental","pubTime":"2026-02-14 04:36","pubTimestamp":1771014960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MEDP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 13, 2026 15:36 ET (20:36 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"gpt_icon":0},{"id":"2611605160","title":"Medpace Shares Rise After Jefferies Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2611605160","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611605160?lang=en_us&edition=fundamental","pubTime":"2026-02-14 03:45","pubTimestamp":1771011942,"startTime":"0","endTime":"0","summary":"Medpace (MEDP) shares were up about 2.8% in recent Friday trading after Jefferies upgraded the company to buy from hold with a $560 price target.Trading volume stood at more than 352,000 shares against a daily average of roughly 286,000.Price: 424.99, Change: +8.95, Percent Change: +2.15","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"gpt_icon":0},{"id":"1112834064","title":"Stock Track | Medpace Soars 5.08% Intraday After Jefferies Upgrade to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=1112834064","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112834064?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:45","pubTimestamp":1770993901,"startTime":"0","endTime":"0","summary":"Medpace's stock soared 5.08% during intraday trading on Friday, reflecting significant investor interest.The surge follows an upgrade by Jefferies analyst David Windley, who raised the rating on Medpace from Hold to Buy with a price target of $560, citing positive developments in biotech funding.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"gpt_icon":0},{"id":"2611549131","title":"Jefferies Upgrades Medpace to Buy From Hold, $560 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2611549131","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611549131?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:37","pubTimestamp":1770986221,"startTime":"0","endTime":"0","summary":"Medpace Holdings (MEDP) has an average rating of Hold and mean price target of $505.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"gpt_icon":0},{"id":"2611156713","title":"Medpace upgraded to Buy from Hold at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2611156713","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611156713?lang=en_us&edition=fundamental","pubTime":"2026-02-13 19:39","pubTimestamp":1770982762,"startTime":"0","endTime":"0","summary":"Jefferies analyst David Windley upgraded Medpace (MEDP) to Buy from Hold with an unchanged price target of $560. The firm says biotech funding has ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-upgraded-to-buy-from-hold-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-upgraded-to-buy-from-hold-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"2611182468","title":"Medpace Holdings Inc : Jefferies Raises to Buy From Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2611182468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611182468?lang=en_us&edition=fundamental","pubTime":"2026-02-13 14:02","pubTimestamp":1770962566,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z9029:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171311.SGD","LU2065171402.SGD","MEDP","BK4588","BK4585","LU2065169927.USD","LU2065170008.USD","BK4121"],"gpt_icon":0},{"id":"2611973559","title":"Why this drug-research company's stock is having its worst day since 1999","url":"https://stock-news.laohu8.com/highlight/detail?id=2611973559","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611973559?lang=en_us&edition=fundamental","pubTime":"2026-02-13 00:10","pubTimestamp":1770912600,"startTime":"0","endTime":"0","summary":"Icon shares plunged, as an accounting probe added to worries in the CRO sector about cancellations and the regulatory environment. Icon's stock is having its worst day since 1999, as an accounting probe added to investors' worries about contract research organizations.Shares of Icon were plummeting on Thursday toward their worst day in decades, as the announcement of an accounting probe added to all the pressures the contract research organization sector has already been feeling.As a result of the investigation, which the company  said it initiated in October, the company withdrew its financial guidance for 2025, saying it plans to release fourth-quarter results \"on or prior to\" April 30, which would be about two months later than usual.The stock sank 36.4% toward a nine-year low in recent trading, and was headed for its worst day since the record 50.9% plunge it suffered on March 30, 1999.\"While the investigation is continuing, at this time, preliminary indications are that the compan","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","BK4121","LU1201861249.SGD","LU0511384066.AUD","LU1983260115.SGD","LU1804176565.USD","LU1989764748.USD","LU0130102774.USD","LU1267930573.SGD","IQV","LU0128525929.USD","LU0994945656.USD","LU1989764664.SGD","LU2265009873.SGD","LU2362541273.HKD","LU2065170008.USD","LU0889566641.SGD","LU2244417387.USD","LU0648001328.SGD","LU0882574055.USD","LU2324357040.USD","LU0792757196.USD","LU0187121727.USD","LU0708994859.HKD","LU1261432733.SGD","BK4588","LU2065171402.SGD","LU0069063385.USD","ICLR","LU0114720955.EUR","LU0289961442.SGD","LU0477156953.USD","BK4530","LU0057025933.USD","LU1267930813.SGD","MEDP","BK4585","LU0289739343.SGD","LU2362541513.USD","LU1043141123.HKD","LU0130518102.USD","LU0980610538.SGD","LU0426412945.USD","LU0130103400.USD","LU1791710582.SGD","LU2065171311.SGD","LU0289960550.SGD","LU0472753341.HKD","LU0477156797.USD","LU0426417589.USD"],"gpt_icon":0},{"id":"2610991003","title":"Assessing Medpace Holdings (MEDP) Valuation After Recent Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2610991003","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610991003?lang=en_us&edition=fundamental","pubTime":"2026-02-12 15:20","pubTimestamp":1770880857,"startTime":"0","endTime":"0","summary":"Medpace Holdings stock overview\nMedpace Holdings (MEDP) has recently drawn investor attention after a period of weaker share performance, with the stock showing declines over the past week, month and past 3 months alongside a lower year to date return.\nSee our latest analysis for Medpace Holdings.\nAt a share price of US$423.93, Medpace’s recent pullback, including a 30 day share price return of a 29.25% decline, contrasts with its 1 year total shareholder return of 25.99%. This hints at...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/assessing-medpace-holdings-medp-valuation-after-recent-share","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/assessing-medpace-holdings-medp-valuation-after-recent-share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","LU2065169927.USD","BK4585","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","MEDP","BK4588"],"gpt_icon":0},{"id":"1108180434","title":"Stock Track | Medpace Plummets 5.04% Intraday Amid Multiple Analyst Price Target Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=1108180434","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108180434?lang=en_us&edition=fundamental","pubTime":"2026-02-12 04:34","pubTimestamp":1770842079,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) saw its stock price plummet 5.04% during Wednesday's intraday trading session. The significant drop came as investors reacted to a wave of negative sentiment from Wall...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"gpt_icon":0},{"id":"2610895487","title":"Truist Securities Adjusts Price Target on Medpace to $539 From $555, Maintains Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2610895487","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610895487?lang=en_us&edition=fundamental","pubTime":"2026-02-11 23:58","pubTimestamp":1770825529,"startTime":"0","endTime":"0","summary":"Medpace (MEDP) has an average rating of hold and mean price target of $505.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"gpt_icon":0},{"id":"2610395348","title":"Medpace price target lowered to $539 from $555 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2610395348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610395348?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:45","pubTimestamp":1770817536,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Medpace (MEDP) to $539 from $555 and keeps a Hold rating on the shares. The firm is updating its model af...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-price-target-lowered-to-539-from-555-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-price-target-lowered-to-539-from-555-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":0.0461},{"period":"1month","weight":-0.1172},{"period":"3month","weight":-0.1205},{"period":"6month","weight":0.0039},{"period":"1year","weight":0.4379},{"period":"ytd","weight":-0.148}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.035449},{"month":3,"riseRate":0.7,"avgChangeRate":0.006551},{"month":4,"riseRate":0.666667,"avgChangeRate":0.005652},{"month":5,"riseRate":0.444444,"avgChangeRate":0.020283},{"month":6,"riseRate":1,"avgChangeRate":0.07437},{"month":7,"riseRate":0.666667,"avgChangeRate":0.148095},{"month":8,"riseRate":0.666667,"avgChangeRate":0.032832},{"month":9,"riseRate":0.6,"avgChangeRate":-0.004448},{"month":10,"riseRate":0.5,"avgChangeRate":0.057543},{"month":11,"riseRate":0.7,"avgChangeRate":0.057867},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Medpace,MEDP,Medpace股票,Medpace股票老虎,Medpace股票老虎国际,Medpace行情,Medpace股票行情,Medpace股价,Medpace股市,Medpace股票价格,Medpace股票交易,Medpace股票购买,Medpace股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}